Delphistem vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Delphistem offers personalized iPSC (induced pluripotent stem cell) banking services, enabling individuals to store their cells at their youngest state for future regenerative medicine and disease detection applications.
About
Delphistem is a longevity-focused biotech company providing induced pluripotent stem cell (iPSC) storage services for individuals seeking to preserve their biological options for future personalized medicine. The company collects biological samples from clients, reprograms them into iPSCs — cells capable of differentiating into virtually any tissue type — and stores them cryogenically for long-term use in future medical treatments, disease risk detection, and cell replacement therapies.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.